Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: A prospective study

International Journal of Urology

Volumn 21, Issue 5, 2014, Pages 453-459

  Kondo, Tsunenori ^a   Hara, Isao ^b   Takagi, Toshio ^a   Kodama, Yoshiki ^b   Hashimoto, Yasunobu ^a   Kobayashi, Hirohito ^a   Iizuka, Junpei ^a   Omae, Kenji ^a   Yoshida, Kazuhiko ^a   Tanabe, Kazunari ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Kidney pelvis; Lymph node excision; Prospective studies; Survival; Ureteral neoplasms; Urothelial carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SPECIFIC SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; KIDNEY PELVIS; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT;

EID: 84899471841     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12338     Document Type: Article

References (27)

1. Roupret M, Zigeuner R, Palou J etal. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur. Urol. 2011; 59: 584-594.
2. Roupret M, Babjuk M, Comperat E etal. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur. Urol. 2013; 63: 1059-1071.
3. Roscigno M, Shariat SF, Margulis V etal. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J. Urol. 2009; 181: 2482-2489.
4. Abe T, Shinohara N, Muranaka M etal. Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes. Eur. J. Surg. Oncol. 2010; 36: 1085-1091.
5. Lughezzani G, Jeldres C, Isbarn H etal. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology 2010; 75: 118-124.
6. Burger M, Shariat SF, Fritsche HM etal. No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study. World J. Urol. 2011; 29: 465-472.
7. Mason RJ, Kassouf W, Bell DG etal. The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience. Urology 2012; 79: 840-845.
8. Ouzzane A, Colin P, Ghoneim TP etal. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy. World J. Urol. 2013; 31: 189-197.
9. Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. J. Urol. 2007; 178: 1212-1217; discussion 1217.
10. Brausi MA, Gavioli M, De Luca G etal. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. Eur. Urol. 2007; 52: 1414-1420.
11. Roscigno M, Cozzarini C, Bertini R etal. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur. Urol. 2008; 53: 794-802.
12. Roscigno M, Shariat SF, Margulis V etal. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur. Urol. 2009; 56: 512-518.
13. Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. Urology 2007; 69: 265-269.
14. Sobin LH, Gospodarpwicz MK, Wittekind CH. Renal plevis and ureter (ICD-O C65, C66). Sobin LH, Gospodarpwicz MK, Wittekind CH (eds.). TNM Classification of Malignant Tumors, 7th edn. Wiley-Liss., New York, 2009; 258-261.
15. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 2004; 240: 205-213.
16. Sagalowsky AI, Jarrett TW. Management of urothelial tumors of the renal pelvis and ureter. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds). Campbell-Walsh Urology, 9th edn. Saunders, New York, 2007; 1653-1685.
17. Rao SR, Correa JJ, Sexton WJ etal. Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma. BJU Int. 2012; 110: E475-480.
18. Kondo T, Hashimoto Y, Kobayashi H etal. Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival. Int. J. Urol. 2010; 17: 848-854.
19. Assouad J, Riquet M, Foucault C, Hidden G, Delmas V. Renal lymphatic drainage and thoracic duct connections: implications for cancer spread. Lymphology 2006; 39: 26-32.
20. Tanaka N, Kikuchi E, Kanao K etal. Patient characteristics and outcomes in metastatic upper tract urothelial carcinoma after radical nephroureterectomy: the experience of Japanese multi-institutions. BJU Int. 2013; 112: E28-34.
21. Akdogan B, Dogan HS, Eskicorapci SY, Sahin A, Erkan I, Ozen H. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J. Urol. 2006; 176: 48-52.
22. Grossman HB, Natale RB, Tangen CM etal. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N. Engl. J. Med. 2003; 349: 859-866.
23. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data. Eur. Urol. 2005; 48: 189-199; discussion 99-201.
24. Sobin LH, Gospodarpwicz MK, Wittekind CH. Urinary bladder (ICD-O C67). Sobin LH, Gospodarpwicz MK, Wittekind CH (eds.). TNM Classification of Malignant Tumors, 7th edn. Wiley-Liss., New York, 2009; 262-265.
25. Jensen JB, Ulhoi BP, Jensen KM. Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery. BJU Int. 2010; 106: 199-205.
26. Kondo T, Tanabe K. Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract. Int. J. Urol. 2012; 19: 710-721.
27. Dangle PP, Gong MC, Bahnson RR, Pohar KS. How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage? J. Urol. 2010; 183: 499-503.